NDC 42571-119-32 - TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42571-119
- Requested NDC
- 42571-119-32
- Package NDCs from labels
- 42571-119-01, 42571-119-05, 42571-119-32, 42571-119-23, 42571-119-90
- Manufacturer
- Micro Labs Limited
- Effective date
- 2025-12-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN - Micro Labs Limited | Micro Labs Limited | 2025-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2021-09-21 | HUMAN PRESCRIPTION DRUG LABEL |
| STARCH, CORN - Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2020-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42571-119-01 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 28 | |
| 42571-119-05 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 28 | |
| 42571-119-23 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 8 in 1 CARTON | TABLET, FILM COATED | 8 | 28 | |
| 42571-119-32 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 28 | |
| 42571-119-90 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 28 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42571-119 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN) TABLET, FILM COATED [MICRO LABS LIMITED] | 27 | Legacy NDC, 5 package rows | 20231228_ab84058e-e52c-4b81-badc-4b0c26aab259.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42571-119-01 | EA - Each | 42571-119 | ca1cbd33-5f32-41c4-bab7-ead0ef80c663 | 1 | 2013-07-02 |
| 42571-119-05 | EA - Each | 42571-119 | fd47a9a1-7410-425d-a3ef-442d09d7f58c | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampigrin Ultra Forte Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e71c3-fe7c-77c7-e053-2995a90a34b2 | 2026-11-04 | Warnings | 362O9ITL9D |
| Nitecin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | dfb56532-6f72-1e4d-e053-2a95a90a1c05 | 2026-11-04 | Warnings | 362O9ITL9D |
| Pentrexcilina Night Time | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e5c17-28f2-7186-e053-2995a90a51f6 | 2026-11-04 | Warnings | 362O9ITL9D |
| Viro Flu PM Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e1553da8-3a89-e258-e053-2a95a90a4725 | 2026-11-04 | Warnings | 362O9ITL9D |
| Activcin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC. | e06a4d72-cc8d-fd9d-e053-2995a90a7a76 | 2026-11-04 | Warnings | 362O9ITL9D |
| Tramadol Hydrochloride | TRAMADOL HYDROCHLORIDE | REMEDYREPACK INC. | ccb3e0f9-57db-40bc-84d2-b66a827a5b96 | 2026-11-03 | Boxed warning, Warnings, Adverse reactions | 9N7R477WCK |
| Dolex Forte | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Pharmadel LLC | 3c2d90fc-130d-476c-e063-6294a90a8c15 | 2026-11-03 | Warnings | 362O9ITL9D |
| VICKS FORMULA 44DM NIGHTTIME COUGH and COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, CHLORPHENIRAMINE MALEATE | Procter & Gamble Manufacturing Company | 05414779-f61d-8fa7-e063-6394a90aa034 | 2026-11-03 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2026-11-02 | Warnings | 362O9ITL9D |
| acetaminophen | ACETAMINOPHEN | REMEDYREPACK INC. | dc430980-5994-4e61-ad3d-181f5fdc769d | 2026-11-02 | Warnings | 362O9ITL9D |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f1157dbc-d86c-4554-954c-60a74674ff6b | 2026-11-02 | Warnings | 362O9ITL9D |
| equate pain reliever | ACETAMINOPHEN | WALMART INC. | 59d01f72-4575-48e2-b914-b6a6456ca7d2 | 2026-11-02 | Warnings | 362O9ITL9D |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 41W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4158f0-c743-29c2-e063-6394a90ac721 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41ecb2-9fe5-ade7-e063-6294a90abc4e | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 43O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f425415-ed84-fc33-e063-6394a90a15f7 | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.